Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Net Income towards Common Stockholders (2016 - 2026)

Argenx Se's (ARGX) quarterly Net Income towards Common Stockholders came in at $472.0 million in Q2 2026, up 92.37% on a YoY basis from $245.4 million in Q2 2025, and up 28.96% quarter-over-quarter from $366.0 million in Q1 2026.

Analysis

Argenx Se (ARGX) Net Income towards Common Stockholders (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Net Income towards Common Stockholders for 11 consecutive years, with $472.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 92.37% year-over-year to $472.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.7 billion (up 34.01% YoY), and the FY2025 full-year result was $1.3 billion, up 55.1% from the prior year.
  • Net Income towards Common Stockholders rose to $472.0 million in Q2 2026 per ARGX's latest filing, from $366.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $774.2 million in Q4 2024 and bottomed at -$235.0 million in Q3 2022.
  • Historically, Net Income towards Common Stockholders has averaged $108.8 million across 5 years, with a median of $97500.0 in 2023.
  • The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders tumbled 1157.6% in 2022, then jumped 880.62% in 2024.
  • Over 5 years, Net Income towards Common Stockholders stood at -$38.6 million in 2022, then slumped by 156.84% to -$99.2 million in 2023, then surged by 880.62% to $774.2 million in 2024, then tumbled by 31.16% to $532.9 million in 2025, then fell by 11.44% to $472.0 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $472.0 million, $366.0 million, and $532.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 5.53 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 3.62 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 2.51 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -10.50 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -238.00 Mn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 1.10 Bn
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn 472.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 472.00 Mn
Mar 31, 2026 366.00 Mn
Dec 31, 2025 532.95 Mn
Sep 30, 2025 344.26 Mn
Jun 30, 2025 245.36 Mn
Mar 31, 2025 169.00 Mn
Dec 31, 2024 774.16 Mn
Sep 30, 2024 91.41 Mn
Jun 30, 2024 29.07 Mn
Mar 31, 2024 -61.60 Mn
Dec 31, 2023 -99.17 Mn
Sep 30, 2023 -72.64 Mn
Jun 30, 2023 -94.37 Mn
Mar 31, 2023 -28.87 Mn
Dec 31, 2022 -38.61 Mn
Sep 30, 2022 -235.04 Mn
Jun 30, 2022 -208.75 Mn
Mar 31, 2022 -227.19 Mn
Dec 31, 2021 -237.82 Mn
Sep 30, 2021 -233.61 Mn
API Access

Argenx Se Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ARGX&period=max&api_key=YOUR_API_KEY